CBC Pain Formulation Without THC Psychoactive Effects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pain management formulations often cause unintended side-effects such as stomach upset and addiction, and the potential of certain cannabinoids like cannabichromene (CBC) has not been fully explored for primary medicinal use.
Innovation Solution
A formulation comprising cannabichromene (CBC) as the primary cannabinoid, essentially free of tetrahydrocannabinol (THC), for managing pain through various delivery forms and methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If opiate drugs are used for pain management, then pain relief is achieved, but risk of addiction and stomach upset occurs
Solution Approach 1:
The patent extracts and isolates specific cannabinoids (CBD, CBC, CBG) from the cannabis plant to create a purified formulation that provides pain relief without the harmful psychoactive effects of THC. This extraction principle separates the beneficial components from the harmful ones, achieving pain management without addiction risk or stomach upset.
Solution Approach 2:
The patent creates a composite cannabinoid formulation containing multiple cannabinoids (CBD, CBC, CBG) in specific ratios. This composite approach synergizes the pain-relieving effects of different cannabinoids while maintaining safety profiles free from opioid-like side effects and addiction potential.
2Quantity of substance
If THC-containing formulations are used for pain management, then analgesic effect is achieved, but psychoactive effects occur
Solution Approach 1:
The patent explicitly excludes THC from the formulation, extracting only the non-psychoactive cannabinoids CBD, CBC, and CBG. This extraction approach maintains effective pain relief while completely eliminating the psychoactive effects associated with THC.
Solution Approach 2:
The patent creates a formulation with specific local qualities by selecting particular cannabinoids with specific properties. CBD provides anti-inflammatory effects, CBC contributes to pain relief without psychoactivity, and CBG adds analgesic properties, creating a localized therapeutic profile tailored for pain management without psychoactive side effects.
Data Source
AI summary
A formulation for pain management is provided comprising cannabichromene as the primary cannabinoid together with an excipient and, optionally, one or more secondary cannabinoids in an amount of up to 5% by weight of the primary cannabinoid. The formulation is essentially free of tetrahydrocannabinol. The types of pain to be managed with the formulation include but are not limited to the treatment of neuropathic pain, pain due to cancer, injury, accident, surgery, or tissue damage. Methods of use of the formulation, doses and dosage forms are described.